Schizophrenia has a different med: “patients who took Cobenfy saw their symptom scores fall by about 20 points, compared with a 10-point drop in the placebo group” 🆓

Link. Nausea main problem so far. No weight gain and maybe some anhedonia relief.

The NYT article is solid except where they use word “rare”. I assume that was a fearful editor. The disease is not rare and it is terrible.

I appreciated the summary of how our genomic studies produced nothing.

🆓 link